Ovarian suppression and exercise in young breast cancer patients
Part of Cancer, Skin clinical trials.
This trial tests whether adding a supervised exercise program helps women with hormone-positive breast cancer who are receiving ovarian suppression therapy. It looks at how exercise affects treatment side effects, quality of life, and long-term health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old and still having periods (or had them before chemo).
- You have been diagnosed with stage I–III breast cancer that is hormone-receptor-positive (ER and/or PR positive).
- You have finished surgery and any needed radiation therapy.
- You are currently taking a medication called a GnRH agonist that turns off your ovaries, and plan to continue it for at least 4 more months.
- You are generally able to do light activity (ECOG score 0 or 1) and have no medical reasons that prevent exercise.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a program of supervised exercise and full follow-up before and after breast cancer treatment can improve recovery and quality of life for women with early-stage breast cancer.
This study tests whether a personalized 14-week exercise program, guided by a physiotherapist, can help people with breast cancer during their chemotherapy or hormone therapy before surgery. It also looks at certain biological markers in blood or tissue samples to learn more about how the body responds to treatment and exercise.
This trial tests whether a supervised exercise and nutrition program can improve well-being for people with ovarian cancer who are taking a maintenance drug called a PARP inhibitor after finishing their first round of chemotherapy. Participation may help manage side effects and support overall health.
This trial studies whether a structured exercise and lifestyle (diet and activity) program can help women with ovarian or endometrial cancer during chemotherapy. You may be assigned to the lifestyle program or usual care to compare outcomes.
This trial tests a special exercise program during chemotherapy before surgery. It may help patients with certain gynecologic cancers get stronger and better prepared for treatment.
This trial tests if a supervised exercise program can improve quality of life for people with early-stage breast cancer who are currently taking hormone therapy (aromatase inhibitors with or without CDK4/6 inhibitors). It aims to see if exercise helps reduce side effects like fatigue and pain.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.